Mid-Year Report
HOSPIRA, INC. for HOSPIRA INC
Firm
Client
Income
—
Expenses
$40,000
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Mid-Year Report | Aug 13, 2007 | $40,000 | Replaced |
| Mid-Year Report (this page) | Aug 13, 2007 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
HR 1038 / S 623: "Access to Life Saving Medicines Act", Support Biogenerics. In the Senate: "The Biologics Price Competition and Innovation Act of 2007", Supports Biogenerics. S 1082: "The FDA Revitalization Act of 2007", Reauthorizes prescription drug and medical device user fee legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.